Global pharma major Lupin Limited (Lupin) announced that it has received an “A-” leadership rating from CDP for its outstanding performance in climate change and water security. This rating reflects ...

Indian drugmakers earn a significant share of revenue from the US, the largest importer of Indian pharma products ...

Ramesh Swaminathan, Global CFO of pharmaceutical company Lupin, warns that Trump tariffs could deny many in the U.S. access ...

The decline in pharma stocks followed comments from President Donald Trump, who indicated that the US may impose tariffs of ...

CDP is a global non-profit that runs the world's only independent environmental disclosure system for companies to manage their environmental impact. As the founder of environmental reporting, CDP ...

The company is focusing on high-growth segments like injectables and complex generics for growth in US market.

Lupin transfers OTC business to subsidiary for Rs ₹550-650 crore, reports strong Q3 financial performance with profit and ...

Ipratropium bromide nasal solution 0.06% is indicated for symptomatic relief of rhinorrhea associated with the common cold or ...

The company reported a profit after tax of ₹8,589 crore, a 38.8% increase from the previous year's ₹6,187 crore. Its total ...

Lupin shares saw a strong recovery on February 12 after the company reported solid Q3 FY25 earnings. The stock, which initially dropped 3.2 per cent to Rs 2,000.10, rebounded nearly 6 per cent to hit ...

The share price of Lupin Ltd. fell over 3% on Wednesday despite a 39.5% jump in its net profit for the quarter ended December. The decline comes as Nifty fell below 23,000 support level. In addition, ...